Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced ...
J.P. Morgan turned cautious on the eVTOL sector as it attempted to balance the near-term relativeshare price outperformance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback